(Q46616703)

23 December 2017

title

Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction (English)

1 reference

23 December 2017

author

Reginald F. Frye

7

1 reference

23 December 2017

author name string

Curtis E Haas

1

1 reference

23 December 2017

Daniel Brazeau

2

1 reference

23 December 2017

Denise Cloen

3

1 reference

23 December 2017

Brent M Booker

4

1 reference

23 December 2017

Valerie Frerichs

5

1 reference

23 December 2017

Colleen Zaranek

6

1 reference

23 December 2017

Thomas Kufel

8

1 reference

23 December 2017

publication date

22 July 2005

1 reference

23 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

61

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

583-593

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-005-0971-0

exact match

0 references

cites work

The influence of enzyme induction on polymorphic sparteine oxidation

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0971-0

The effect of rifampin treatment on intestinal expression of human MRP transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0971-0

The use of caffeine as a metabolic probe for human drug metabolizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0971-0

Three new alternative splicing variants of human cytochrome P450 2D6 mRNA in human extratumoral liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0971-0

CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects.

21 January 2018

1 reference

12 December 2020

Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease

1 reference

12 December 2020

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

1 reference

12 December 2020

CYP2D6 mRNA expression in circulating peripheral blood mononuclear cells correlates with in vivo debrisoquine hydroxylase activity in extensive metabolizers

1 reference

12 December 2020

Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker

1 reference

12 December 2020

An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity

1 reference

12 December 2020

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism

1 reference

12 December 2020

Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen

1 reference

12 December 2020

Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin

1 reference

12 December 2020

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

1 reference

12 December 2020

Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells

1 reference

12 December 2020

Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport

1 reference

12 December 2020

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

1 reference

12 December 2020

Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR

1 reference

12 December 2020

Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism

1 reference

12 December 2020

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.

1 reference

12 December 2020

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

1 reference

12 December 2020

Expression of the CYP1A1 gene in peripheral lymphocytes as a marker of exposure to creosote in railroad workers

1 reference

12 December 2020

Only truncated, not complete cytochrome p450 2D6 RNA transcript and no detectable enzyme activity are expressed in human lymphocytes

1 reference

12 December 2020

Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver

1 reference

12 December 2020

Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes

1 reference

12 December 2020

Computation of model-independent pharmacokinetic parameters during multiple dosing

1 reference

12 December 2020

CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin

1 reference

12 December 2020

Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes

1 reference

12 December 2020

Orphan receptor promiscuity in the induction of cytochromes p450 by xenobiotics

1 reference

12 December 2020

Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

1 reference

12 December 2020

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

1 reference

12 December 2020

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study

1 reference

12 December 2020

Drug metabolizing enzymes in lymphocytes

1 reference

12 December 2020

Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity.

1 reference

12 December 2020

Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors

1 reference

12 December 2020

Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics

1 reference

12 December 2020

Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver

1 reference

12 December 2020

Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".

1 reference

12 December 2020

Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level.

1 reference

12 December 2020

An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A)

1 reference

12 December 2020

Recent advances: the cytochrome P450 enzymes.

1 reference

12 December 2020

Improved high-performance liquid chromatographic determination of debrisoquine and 4-hydroxydebrisoquine in human urine following direct injection

1 reference

12 December 2020

Determination of CYP2C19 phenotype in black Americans with omeprazole: correlation with genotype

1 reference

12 December 2020

Induction of CYP2C genes in human hepatocytes in primary culture

1 reference

12 December 2020

Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues

1 reference

12 December 2020

The use of caffeine for enzyme assays: a critical appraisal

1 reference

12 December 2020

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam.

1 reference

12 December 2020

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

1 reference

12 December 2020

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

1 reference

12 December 2020

Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays

1 reference

12 December 2020

In vivo modulation of CYP enzymes by quinidine and rifampin

1 reference

12 December 2020

Quantitative RT-PCR for CYP3A4 mRNA in human peripheral lymphocytes: induction of CYP3A4 in lymphocytes and in liver by rifampicin

1 reference

12 December 2020

CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes

1 reference

12 December 2020

Intra-individual variation and sex differences in gene expression of cytochromes P450 in circulating leukocytes

1 reference

12 December 2020

Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation

1 reference

12 December 2020

A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites

1 reference

12 December 2020

Noninvasive tests of CYP3A enzymes

1 reference

12 December 2020

Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes

1 reference

12 December 2020

Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans

1 reference

12 December 2020

Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Pharmacogenetic determinants of codeine induction by rifampin: the impact on codeine's respiratory, psychomotor and miotic effects

1 reference

12 December 2020

Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes

1 reference

12 December 2020

Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

1 reference

12 December 2020

10.1007/S00228-005-0971-0

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017